de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

New research suggests that stress hormones, rather than impaired insulin signaling, may primarily drive diabetes in obesity.

Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.

The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...

Today, doctors have many alternative medication choices with little or no addictive potential. The treatment of choice for ...

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...

Anna* was always taught doctors and the medical system were there to help, not harm. Now she feels a cold sense of ...

Neuropathic pain affects more than 20 million people in the U.S., and at least a quarter of these cases are puzzling for ...

2 other commonly prescribed drugs that also inhibit reuptake of norepinephrine and serotonin. Methods: Information from the French Thales electronic health record database from 2001 to 2007 was used.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are two of the most common types of medications used to treat conditions such as depression, ...

Therefore, you cannot start MAOIs within seven days of stopping SNRIs. You cannot start SNRIs within 14 days of stopping an MAOI. Inform your healthcare provider if you are taking or plan to take any ...

It is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors, or SNRIs. The drug works by increasing the amounts of serotonin and norepinephrine, substances in ...